SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-031985
Filing Date
2022-06-09
Accepted
2022-06-09 16:05:55
Documents
12
Period of Report
2022-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea161338-8k_protara.htm   iXBRL 8-K 30782
  Complete submission text file 0001213900-22-031985.txt   203864

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tara-20220608.xsd EX-101.SCH 2992
3 XBRL LABEL FILE tara-20220608_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE tara-20220608_pre.xml EX-101.PRE 22381
6 EXTRACTED XBRL INSTANCE DOCUMENT ea161338-8k_protara_htm.xml XML 3613
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 221005991
SIC: 2836 Biological Products, (No Diagnostic Substances)